Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.02.049
Abstract: BACKGROUND Anthracycline (ANT) chemotherapy is associated with cardiotoxicity. Prevention with β-blockers remains controversial. OBJECTIVES This prospective, randomized, double-blind, placebo-controlled study sought to evaluate the role of carvedilol in preventing ANT cardiotoxicity. METHODS The authors randomized… read more here.
Keywords: chemotherapy; carvedilol group; cardiotoxicity; carvedilol ... See more keywords